Literature DB >> 17299957

[Study on the prevalence of metabolic syndrome among 35-74 year-olds in Jiangsu province].

Xiao-Shu Hu1, Zhi-Rong Guo, Hui Zhou, Zu-Min Shi, Ming Wu, Jun Zhang, Guo-Xiang Sun, Zheng-Yuan Zhou, Xiao-Qun Pan, Cai-Liang Yao.   

Abstract

OBJECTIVE: To describe the prevalence of metabolic syndrome (MS) in Jiangsu province, using IDF 2005 and ATP III 2005 definition.
METHODS: Multistage cluster sampling method was used and the participants were interviewed by trained health workers under a structured questionnaire. The number of research subjects was 5888. Fasting plasma glucose (FPG), blood lipids, body mass index, blood pressure (BP) of all sample population (5888 subjects) were measured.
RESULTS: The prevalence of MS was 17.48% by IDF 2005 definition and 21.95% by ATP lII 2005 definition. Women had higher prevalence than men (P < 0.01). The prevalence of MS increased with age. Abrupt increase of the prevalence started at age of 50 in women. The prevalence varied by education, marital status, occupation and income. People from the urban and the south had a higher prevalence than from the rural and from the northern part of the country. The most common combination of MS individual components were 1) central obesity, dislipidemia and high BP; 2) central obesity, dislipidemia, high BP and high FPG.
CONCLUSION: The prevalence of MS was high in Jiangsu province. Clustering of MS components was common. It is necessary to discuss the cut-off points of central obesity for the waist circumference diagnostic criteria of MS in Chinese population. The importance of prevention of MS should be strengthened both by health professionals and the government.

Entities:  

Mesh:

Year:  2006        PMID: 17299957

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  8 in total

1.  Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han population.

Authors:  Wei Fan; Chao Shen; Ming Wu; Zheng-Yuan Zhou; Zhi-Rong Guo
Journal:  Genet Test Mol Biomarkers       Date:  2015-06-22

2.  Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population.

Authors:  Shu-Jun Gu; Dong-Hui Chen; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Endocrine       Date:  2014-03-07       Impact factor: 3.633

3.  Analysis on the association between PPARα/γ polymorphisms and lipoprotein(a) in a Chinese Han population.

Authors:  Hui-Jian Xie; Bo Hai; Ming Wu; Qiu Chen; Meng-Meng Liu; Chen Dong; Zhi-Rong Guo
Journal:  Mol Genet Genomics       Date:  2014-06-01       Impact factor: 3.291

4.  Using brachial-ankle pulse wave velocity to screen for metabolic syndrome in community populations.

Authors:  Guanghua Wang; Liang Zheng; Xiankai Li; Juanli Wu; Lijuan Zhang; Jie Zhang; Liling Zou; Xin Li; Yi Zhang; Qian Zhou; Huimin Fan; Yang Li; Jue Li
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

5.  The Effects of Dietary Pattern on Metabolic Syndrome in Jiangsu Province of China: Based on a Nutrition and Diet Investigation Project in Jiangsu Province.

Authors:  Yuanyuan Wang; Yue Dai; Ting Tian; Jingxian Zhang; Wei Xie; Da Pan; Dengfeng Xu; Yifei Lu; Shaokang Wang; Hui Xia; Guiju Sun
Journal:  Nutrients       Date:  2021-12-13       Impact factor: 5.717

6.  PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Lipids Health Dis       Date:  2014-01-26       Impact factor: 3.876

7.  The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China.

Authors:  Chen Chen; Yan Xu; Zhi-rong Guo; Jie Yang; Ming Wu; Xiao-shu Hu
Journal:  Lipids Health Dis       Date:  2014-07-08       Impact factor: 3.876

8.  Haplotype Analysis of PPARγ Gene Polymorphisms and the Lipoprotein (a) Level.

Authors:  Chao Shen; Wei Fan; Hui-Jian Xie; Ming Wu; Zheng-Yuan Zhou; Zhi-Rong Guo; Chen Dong
Journal:  Iran J Public Health       Date:  2018-07       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.